列线图
医学
比例危险模型
单变量
无线电技术
多元分析
结直肠癌
多元统计
放射科
肿瘤科
内科学
癌症
统计
数学
作者
Guodong Xu,Feng Feng,Yanfen Cui,Yigang Fu,Yong Xiao,Wang Chen,Manman Li
标识
DOI:10.1177/02841851241302521
摘要
Background Radiomics analysis is widely used to assess tumor prognosis. Purpose To explore the value of computed tomography (CT) radiomics nomogram in predicting disease-free survival (DFS) of patients with colorectal cancer (CRC) after operation. Material and Methods A total of 522 CRC patients from three centers were retrospectively included. Radiomics features were extracted from CT images, and the least absolute shrinkage and selection operator Cox regression algorithm was employed to select radiomics features. Clinical risk factors associated with DFS were selected through univariate and multivariate Cox regression analysis to build the clinical model. A predictive nomogram was developed by amalgamating pertinent clinical risk factors and radiomics features. The predictive performance of the nomogram was evaluated using the C-index, calibration curve, and decision curve. DFS probabilities were estimated using the Kaplan–Meier method. Results Integrating the retained eight radiomics features and three clinical risk factors (pathological N stage, microsatellite instability, perineural invasion), a nomogram was constructed. The C-index for the nomogram were 0.819 (95% CI=0.794–0.844), 0.782 (95% CI=0.740–0.824), 0.786 (95% CI=0.753–0.819), and 0.803 (95% CI=0.765–0.841) in the training set, internal validation set, external validation set 1, and external validation set 2, respectively. The calibration curves demonstrated a favorable congruence between the predicted and observed values as depicted by the nomogram. The decision curve analysis underscored that the nomogram yielded a heightened clinical net benefit. Conclusion The constructed radiomics nomogram, amalgamating the radiomics features and clinical risk factors, exhibited commendable performance in the individualized prediction of postoperative DFS in CRC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI